Department of Biology
Vera Gorbunova has not added Biography.
If you are Vera Gorbunova and would like to personalize this page please email our Author Liaison for assistance.
CLK-1 protein has DNA binding activity specific to O(L) region of mitochondrial DNA.
FEBS letters Apr, 2002 | Pubmed ID: 11959146
Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis.
The Journal of biological chemistry Oct, 2002 | Pubmed ID: 12140282
Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts.
The Journal of biological chemistry Feb, 2003 | Pubmed ID: 12496279
Selectable system for monitoring the instability of CTG/CAG triplet repeats in mammalian cells.
Molecular and cellular biology Jul, 2003 | Pubmed ID: 12808091
Telomerase as a growth-promoting factor.
Cell cycle (Georgetown, Tex.) Nov-Dec, 2003 | Pubmed ID: 14504469
Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan, 2004 | Pubmed ID: 14722035
DNA end joining becomes less efficient and more error-prone during cellular senescence.
Proceedings of the National Academy of Sciences of the United States of America May, 2004 | Pubmed ID: 15123826
Genome-wide demethylation destabilizes CTG.CAG trinucleotide repeats in mammalian cells.
Human molecular genetics Dec, 2004 | Pubmed ID: 15459182
Making ends meet in old age: DSB repair and aging.
Mechanisms of ageing and development Jun-Jul, 2005 | Pubmed ID: 15888314
Cell divisions are required for L1 retrotransposition.
Molecular and cellular biology Feb, 2007 | Pubmed ID: 17145770
Telomerase activity coevolves with body mass not lifespan.
Aging cell Feb, 2007 | Pubmed ID: 17173545
TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2007 | Pubmed ID: 17670947
Changes in the level and distribution of Ku proteins during cellular senescence.
DNA repair Dec, 2007 | Pubmed ID: 17686666
Changes in DNA repair during aging.
Nucleic acids research , 2007 | Pubmed ID: 17913742
Genome-wide demethylation promotes triplet repeat instability independently of homologous recombination.
DNA repair Feb, 2008 | Pubmed ID: 18083071
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
Lancet Dec, 2007 | Pubmed ID: 18156031
Coevolution of telomerase activity and body mass in mammals: from mice to beavers.
Mechanisms of ageing and development Jan-Feb, 2009 | Pubmed ID: 18387652
Comparison of nonhomologous end joining and homologous recombination in human cells.
DNA repair Oct, 2008 | Pubmed ID: 18675941
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells.
Cell cycle (Georgetown, Tex.) Sep, 2008 | Pubmed ID: 18769152
Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan.
Aging cell Dec, 2008 | Pubmed ID: 18778411
Use of the Rad51 promoter for targeted anti-cancer therapy.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2008 | Pubmed ID: 19106292
Rodents for comparative aging studies: from mice to beavers.
Age (Dordrecht, Netherlands) Sep, 2008 | Pubmed ID: 19424861
DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.
Neoplasia (New York, N.Y.) Jul, 2009 | Pubmed ID: 19568413
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial.
Onkologie Sep, 2009 | Pubmed ID: 19745590
Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2009 | Pubmed ID: 19858485
Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2010 | Pubmed ID: 20159816
SIRT6 promotes DNA repair under stress by activating PARP1.
Science (New York, N.Y.) Jun, 2011 | Pubmed ID: 21680843
SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells.
Cell cycle (Georgetown, Tex.) Sep, 2011 | Pubmed ID: 21900744
Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair.
Aging Sep, 2011 | Pubmed ID: 21946623
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Molecular therapy : the journal of the American Society of Gene Therapy Feb, 2012 | Pubmed ID: 22008909
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Lancet Dec, 2011 | Pubmed ID: 22056247
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jan, 2012 | Pubmed ID: 22173662
Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells.
PloS one , 2011 | Pubmed ID: 22174876
SIRT1 as a therapeutic target in inflammaging of the pulmonary disease.
Preventive medicine Dec, 2011 | Pubmed ID: 22178470
Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins.
Pharmacogenomics Jan, 2012 | Pubmed ID: 22188361
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.